Sarcoidosis activity: Correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay

Journal of Computer Assisted Tomography

Volumn 22, Issue 2, 1998, Pages 229-234

  Leung, Ann N ^a,c   Brauner, Michel W ^b   Caillat Vigneron, Nadine ^b   Valeyre, Dominique ^b   Grenier, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchi; Computed tomography; Gallium; Lavage; Lungs, diseases; Sarcoidosis

Indexed keywords

BIOLOGICAL ORGANS; BODY FLUIDS; ENZYMES; GALLIUM; GLASS; OPACITY; PULMONARY DISEASES;

ANGIOTENSIN-CONVERTING ENZYME; BRONCHUS; COMPUTED TOMOGRAPHY; CT-SCAN; ENZYME ASSAYS; GROUND GLASS; HIGH RESOLUTION CT; LAVAGE; SARCOIDOSIS; SURFACE AREA;

COMPUTERIZED TOMOGRAPHY;

DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; ENZYME ASSAY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0031978052     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199803000-00013     Document Type: Article

References (21)

1. Crystal RG, Roberts WC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981;94:73-94.
2. Abe S, Munakata M, Nishimura M, et al. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest 1984;85:650-5.
3. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract (part II). N Engl J Med 1984;310:235-44.
4. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-60.
5. Lynch DA, Webb WR, Gamsu G, Stulbarg M, Golden J. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989;13:405-10.
6. Bergin CJ, Bell DY, Coblentz CL, et al. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 1989;171:619-24.
7. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992;182:349-54.
8. Murdoch J, Müller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR 1992;159:473-7.
9. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994;191:675-80.
10. Johnson DG, Johnson SM, Harris CC, Piantadosi CA, Blinder RA, Coleman RE. Ga-67 uptake in the lung in sarcoidosis. Radiology 1984;150:551-5.
11. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97:149-206.
12. Costabel U, du Bois R, Eklund A, et al. World Association of Sarcoidosis and Other Granulomatous Disorders Consensus Conference: activity of sarcoidosis. Eur Respir J 1994;7:624-7.
13. Sharma OP. Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 1993;147:1598-600.
14. Alavi A, Palevsky HI. Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. J Nucl Med 1992;33:751-5.
15. Brauner MW, Grenier P, Mompoint D, Lenoir S, Cremoux HD. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 1989;172:467-71.
16. Nishimura K, Itoh H, Kitaichi M, Nagai S, Izumi T. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 1993;189:105-9.
17. Peterson MW, Nugent KM, Jolles H, Monick M, Hunninghake GW. Uniformity of bronchoalveolar lavage in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1988;137:79-84.
18. Ward K, O'Connor C, Odium C, Fitzgerald MX. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989;44:6-12.
19. Drent M, van Velzen-Blad H, Diamant M, Hoogsteden HC, van den Bosch JMM. Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993;104:795-800.
20. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990;142:1268-71.
21. Leung AN, Miller RR, Müller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology 1993;188:209-14.